These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 1580034)
21. Intracavernous vasoactive pharmacotherapy: the impact of a new self-injection device. Montorsi F; Guazzoni G; Bergamaschi F; Orlandini A; Da Pozzo L; Barbieri L; Rigatti P J Urol; 1993 Dec; 150(6):1829-32. PubMed ID: 7693979 [TBL] [Abstract][Full Text] [Related]
22. Intracavernous self-injection therapy for the treatment of erectile dysfunction. Chiang HS; Wen TC; Wu CC; Chiang WH J Formos Med Assoc; 1992 Sep; 91(9):898-901. PubMed ID: 1363391 [TBL] [Abstract][Full Text] [Related]
23. An improved vasoactive drug combination for a pharmacological erection program. Bennett AH; Carpenter AJ; Barada JH J Urol; 1991 Dec; 146(6):1564-5. PubMed ID: 1719248 [TBL] [Abstract][Full Text] [Related]
24. Reasons for patient drop-out from an intracavernous auto-injection programme for erectile dysfunction. Armstrong DK; Convery AG; Dinsmore WW Br J Urol; 1994 Jul; 74(1):99-101. PubMed ID: 8044533 [TBL] [Abstract][Full Text] [Related]
25. Intracavernous pharmacotherapy for impotence: selection of appropriate agent and dose. von Heyden B; Donatucci CF; Kaula N; Lue TF J Urol; 1993 May; 149(5 Pt 2):1288-90. PubMed ID: 8479018 [TBL] [Abstract][Full Text] [Related]
26. Intracavernosal drug-induced erection therapy versus external vacuum devices in the treatment of erectile dysfunction. Soderdahl DW; Thrasher JB; Hansberry KL Br J Urol; 1997 Jun; 79(6):952-7. PubMed ID: 9202565 [TBL] [Abstract][Full Text] [Related]
27. Sexual, psychological, and marital impact of self-injection of papaverine and phentolamine: a long-term prospective study. Althof SE; Turner LA; Levine SB; Risen CB; Bodner D; Kursh ED; Resnick MI J Sex Marital Ther; 1991; 17(2):101-12. PubMed ID: 1920466 [TBL] [Abstract][Full Text] [Related]
28. Intracavernous drug-induced erections in the management of male erectile dysfunction: experience with 100 patients. Sidi AA; Cameron JS; Duffy LM; Lange PH J Urol; 1986 Apr; 135(4):704-6. PubMed ID: 2421014 [TBL] [Abstract][Full Text] [Related]
29. Intracavernous self-injection for erectile failure. Ruutu M; Lindström BL; Virtanen J; Alfthan O Eur Urol; 1988; 15(1-2):96-8. PubMed ID: 3215245 [TBL] [Abstract][Full Text] [Related]
30. [Preliminary results of the treatment of erectile impotence by intracavernous self administration of vasoactive substances]. Stief CG; Bähren W; Beckert R; Altwein JE J Urol (Paris); 1986; 92(6):349-51. PubMed ID: 3794379 [TBL] [Abstract][Full Text] [Related]
31. [Corpus cavernosum injection treatment of erectile impotence]. Lenk S; Schönherr G; Korner I Z Urol Nephrol; 1990 Oct; 83(10):539-46. PubMed ID: 2095661 [TBL] [Abstract][Full Text] [Related]
32. Comparison of Alprostadil (Caverject) and a combination of vasoactive drugs as local injections for the treatment of erectile dysfunction. Abdallah HM Int Urol Nephrol; 1998; 30(5):617-20. PubMed ID: 9934808 [TBL] [Abstract][Full Text] [Related]
34. Intracavernous injection of prostaglandin E1 in combination with papaverine: enhanced effectiveness in comparison with papaverine plus phentolamine and prostaglandin E1 alone. Floth A; Schramek P J Urol; 1991 Jan; 145(1):56-9. PubMed ID: 1984099 [TBL] [Abstract][Full Text] [Related]
35. The application of intracavernous injection of vasoactive medications for erection in men with spinal cord injury. Bodner DR; Lindan R; Leffler E; Kursh ED; Resnick MI J Urol; 1987 Aug; 138(2):310-1. PubMed ID: 3599245 [TBL] [Abstract][Full Text] [Related]
36. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction. Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187 [TBL] [Abstract][Full Text] [Related]